Discussion GLP-1RAs have changed the therapeutic paradigm of T2D as they significantly improve glucose control, also contributing to pleiotropic effects, especially at the cardiovascular level (60), in different clinical scenarios and therapeutic approaches
All compounded GLP-1 medications prescribed through Eden come from licensed, US-based compounding pharmacies that undergo third-party testing
No data were excluded from analysis
CrossRef Determinants of body weight regulation in humans Milene Moehlecke, Luis Henrique Canani, Lucas Oliveira Junqueira e Silva, Manoel Roberto Maciel Trindade, Rogerio Friedman, Cristiane Bauermann Leito Archives of Endocrinology and Metabolism.2016
This suggests that the formulary change may have not only increased AOM semaglutide prescriptions but also increased first-time use of AOM semaglutide
More questions than answers